Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA Agenda For 2005 Includes Medicare Start-Up, Liability Reform

Executive Summary

The Pharmaceutical Research & Manufacturers of America will be supporting medical malpractice reform measures at the state level as part of its agenda for 2005

You may also be interested in...



Pfizer Supports Stronger FDA Oversight Of DTC Promotions

Pfizer supports stronger "external oversight" of direct-to-consumer advertising, CEO Hank McKinnell says in his recently released book A Call To Action: Taking Back Healthcare for Future Generations.

Pfizer Supports Stronger FDA Oversight Of DTC Promotions

Pfizer supports stronger "external oversight" of direct-to-consumer advertising, CEO Hank McKinnell says in his recently released book A Call To Action: Taking Back Healthcare for Future Generations.

PhRMA Launching National Patient Assistance Clearinghouse April 5

The Pharmaceutical Research & Manufacturers of America's "Partnership for Patient Assistance" clearinghouse for prescription drug support programs will roll out nationwide April 5

Related Content

Topics

UsernamePublicRestriction

Register

OM001644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel